Isacke C M, Sauvage C A, Hyman R, Lesley J, Schulte R, Trowbridge I S
Immunogenetics. 1986;23(5):326-32. doi: 10.1007/BF00398797.
Two monoclonal antibodies have been raised against human Pgp-1 by the immunization of mice with human fibroblasts. The human molecule, like the previously identified mouse counterpart, is an abundant membrane protein (Mr approximately 95 000) with a broad tissue distribution. Pgp-1 is phosphorylated, and phosphoamino acid analysis demonstrates that this occurs exclusively on serine residues. A major difference between the mouse and the human is that 50-60% of human thymocytes are Pgp-1+ compared to 5-10% of mouse thymocytes at an equivalent stage in development. Immunofluorescence studies of cryostat sections showed that the majority of human medullary thymocytes are strongly stained with Pgp-1-specific antibody, whereas the expression of Pgp-1 on cortical thymocytes is much more heterogeneous.
通过用人成纤维细胞免疫小鼠,已产生了两种针对人Pgp-1的单克隆抗体。该人类分子与先前鉴定的小鼠对应物一样,是一种丰富的膜蛋白(分子量约为95000),具有广泛的组织分布。Pgp-1发生磷酸化,磷酸氨基酸分析表明这种磷酸化仅发生在丝氨酸残基上。小鼠和人类之间的一个主要差异是,在发育的同等阶段,50%-60%的人类胸腺细胞是Pgp-1阳性,而小鼠胸腺细胞的这一比例为5%-10%。对冰冻切片的免疫荧光研究表明,大多数人类髓质胸腺细胞被Pgp-1特异性抗体强烈染色,而Pgp-1在皮质胸腺细胞上的表达则更为不均一。